Sign inGet started

Weiland Robert J.

Insider CIK 1670648 · CBAY Director · PCRX Chief Commercial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CBAY CymaBay Therapeutics, Inc. A Award deriv2019-01-292019-01-3127,705— $027,705SEC↗
PCRX Pacira Pharmaceuticals, In S Sale2018-06-042018-06-06373$33.02 $12.3K5,088SEC↗
CBAY CymaBay Therapeutics, Inc. A Award deriv2018-01-242018-01-2616,000— $016,000SEC↗
CBAY CymaBay Therapeutics, Inc. A Award deriv2017-09-222017-09-267,500— $07,500SEC↗
CBAY CymaBay Therapeutics, Inc. A Award deriv2017-06-282017-06-3015,000— $015,000SEC↗
PCRX Pacira Pharmaceuticals, In A Award deriv2017-06-142017-06-169,000— $09,000SEC↗
PCRX Pacira Pharmaceuticals, In A Award2017-06-142017-06-164,500— $04,864SEC↗
CBAY CymaBay Therapeutics, Inc. A Award deriv2017-01-192017-01-2312,000— $012,000SEC↗
PCRX Pacira Pharmaceuticals, In A Award deriv2016-12-072016-12-0916,000— $016,000SEC↗
PCRX Pacira Pharmaceuticals, In A Award deriv2016-06-152016-06-1710,000— $010,000SEC↗
PCRX Pacira Pharmaceuticals, In A Award deriv2016-05-032016-05-0440,000— $040,000SEC↗
CBAY CymaBay Therapeutics, Inc. A Award deriv2016-04-262016-04-2818,000— $018,000SEC↗